JACOB WHITNEY
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant GILBERT, AZ NPI 1770119083
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant AZ ABBVIE INC. All categories
General Payments — all program years on this page
$12,518.55
- Category: General Payments
- Program years: PY2021–2024
- Record count: 805
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,899.42 across 113 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,899.42 | 113 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $425.47 | 37 |
| Biogen, Inc. | $168.06 | 8 |
| UCB, Inc. | $166.05 | 14 |
| EISAI INC. | $161.48 | 8 |
| Lilly USA, LLC | $151.78 | 8 |
| Alexion Pharmaceuticals, Inc. | $98.01 | 4 |
| ARGENX US, INC. | $89.65 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $75.68 | 4 |
| Averitas Pharma Inc. | $71.23 | 3 |
| Lundbeck LLC | $55.24 | 2 |
| Genentech USA, Inc. | $53.67 | 2 |
| Neurocrine BioSciences, Inc. | $49.65 | 2 |
| Merz Pharmaceuticals, LLC | $44.16 | 2 |
| CSL Behring | $34.43 | 1 |
| PFIZER INC. | $28.12 | 2 |
| Sumitomo Pharma America, Inc. | $27.32 | 2 |
| GENZYME CORPORATION | $26.71 | 1 |
| Mallinckrodt Hospital Products Inc. | $26.53 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.74 | 1 |
| EMD Serono, Inc. | $22.02 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.35 | 1 |
| TG THERAPEUTICS, INC. | $17.42 | 1 |
| Acorda Therapeutics, Inc | $17.07 | 1 |
| GE HEALTHCARE | $16.27 | 1 |
| Neurelis, Inc. | $13.83 | 1 |
| SCILEX PHARMACEUTICALS INC. | $13.48 | 1 |
By program year
Records — PY2024 (113)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.